News
26 June, 2024 26 June, 2024 Announcement of the President od the Agency for Health Technology Assessment and Tarff System of 25 June, 20204 on the tariffs of guaranteed services of hospital treatment in the area of gastrointestinal diseases
read more26 June, 2024 Announcement of the President od the Agency for Health Technology Assessment and Tarff System of 25 June 2024, on tariffs of guaranteed services for inpatient treatment in the area of diseases of the liver, biliary tract, pancreas and spleen
read more25 June, 2024 Opinion of the President – Health policy program in the field of infertility treatment by means of in vitro fertilization – in vitro for the residents of the Municipality of the City of Inowrocław for the years 2024-2026
read more25 June, 2024 Opinion of the President – Prevention and early detection of testicular cancer among men aged 20-39, residing in Poznań, in 2024-2026
read more21 June, 2024 Recommendation of the President – Tecartus (brexucabtagene autoleucel)
read more20 June, 2024 Recommendation of the President – Vesoxx (oxybutynini hydrochloridum
read more20 June, 2024 Recommendation of the President – specialist lactation advice by
read more20 June, 2024 Recommendation of the President – specialist lactation advice by a doctor
read more20 June, 2024 Position of the Transparency Council – on the appropriateness of issuing approvals for reimbursement of foodstuffs Foodstuffs for special nutritional use S.O.S. 10, S.O.S. 15, S.O.S. 20, S.O.S. 25
read more20 June, 2024 Opinion of the Transparency Council – prednisonum
read more20 June, 2024 Position of the Transparency Council – specialized lactacion advice by a doctor and mildwife
read more20 June, 2024 Opinion of the Transparency Council – salbutamolum
read more20 June, 2024 Opinion of the Transparency Council – amantadine
read more20 June, 2024 Position of the Transparency Council – Vesoxx (oxybutynini hydrochloridum)
read more20 June, 2024 Position of the Transparency Council – Tecartus (brexucabtagene autoleucel)
read more20 June, 2024 Communication of the meeting of Transparency Council No. 26/2024
read more20 June, 2024 Recommendation of the President – Akkega
read more23 May, 2023 Opinion of the Transparency Council – dexamethasone
read more23 May, 2023 Opinion of the Transparency Council – amendments to part B of the drug programme B.70
read more23 May, 2023 Opinion of the Transparency Council – health policy programme of the City of Białystok
read more23 May, 2023 Opinion of the Transparency Council – health policy programme of the City of Zduńska Wola
read more23 May, 2023 Position of the Transparency Council – Adtralza (tralokinumab)
read more22 May, 2023 Meeting of the Transparency Council 20/2023 on 22 May 2023 – Update
read more